|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/48 | |
| C07F 9/6512 | |||
| A61P 31/20 |
| (11) | Patento numeris | 2155257 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08743275.3 |
| Europos patento paraiškos padavimo data | 2008-04-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-02-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-10-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/005322 |
| Data | 2008-04-25 |
| (87) | Numeris | WO 2008/133966 |
| Data | 2008-11-06 |
| (30) | Numeris | Data | Šalis |
| 914532 P | 2007-04-27 | US |
| (72) |
PAINTER, George R., US
|
| (73) |
Chimerix, Inc.,
2505 Meridian Parkway, Suite 340, Durham, NC 27713,
US
|
| (54) | METHODS OF REDUCING NEPHROTOXICITY IN SUBJECTS ADMINISTERED WITH NUCLEOSIDE |
| METHODS OF REDUCING NEPHROTOXICITY IN SUBJECTS ADMINISTERED WITH NUCLEOSIDE |